◆英語タイトル：Silence Therapeutics Plc (SLN) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company’s pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascular disease with high Lp(a); SLN500 for complement-medicated diseases and SLN360 for e-Thalassaemia and myelodysplastic syndrome. Silence Therapeutics also provides RNA interface that include short interfering RNA (siRNA) and messenger RNAs (mRNA). The company collaborates with pharmaceutical, biotechnology companies and academic research institutions. It operates in Germany and the UK. Silence Therapeutics is headquartered in London, the UK.
Silence Therapeutics Plc Key Recent Developments
Mar 30,2021: Silence Therapeutics Reports Full-year 2020 Results
Feb 26,2021: Silence Therapeutics and Mallinckrodt initiate work on third target as part of ongoing RNAi research collaboration for complement-mediated diseases
Jan 06,2021: Silence Therapeutics appoints Michael H. Davidson, MD, to Board of Directors
Jan 06,2021: Silence Therapeutics appoints Craig Tooman as Chief Financial Officer
Nov 02,2020: Silence Therapeutics appoints Dr. Marie Wikstrom
This comprehensive SWOT profile of Silence Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Silence Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Silence Therapeutics Plc – Key Information
Silence Therapeutics Plc – Overview
Silence Therapeutics Plc – Key Employees
Silence Therapeutics Plc – Key Employee Biographies
Silence Therapeutics Plc – Key Operational Heads
Silence Therapeutics Plc – Major Products and Services
Silence Therapeutics Plc – History
Silence Therapeutics Plc – Company Statement
Silence Therapeutics Plc – Locations And Subsidiaries
Silence Therapeutics Plc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Silence Therapeutics Plc – Business Description
Silence Therapeutics Plc – Corporate Strategy
Silence Therapeutics Plc – SWOT Analysis
SWOT Analysis – Overview
Silence Therapeutics Plc – Strengths
Silence Therapeutics Plc – Weaknesses
Silence Therapeutics Plc – Opportunities
Silence Therapeutics Plc – Threats
Silence Therapeutics Plc – Key Competitors
Section 3 – Company Financial Performance Charts
Silence Therapeutics Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Silence Therapeutics Plc, Key Information
Silence Therapeutics Plc, Key Ratios
Silence Therapeutics Plc, Share Data
Silence Therapeutics Plc, Major Products and Services
Silence Therapeutics Plc, History
Silence Therapeutics Plc, Key Employees
Silence Therapeutics Plc, Key Employee Biographies
Silence Therapeutics Plc, Key Operational Heads
Silence Therapeutics Plc, Other Locations
Silence Therapeutics Plc, Subsidiaries
Silence Therapeutics Plc, Key Competitors
Silence Therapeutics Plc, SWOT Analysis
Silence Therapeutics Plc, Ratios based on current share price
Silence Therapeutics Plc, Annual Ratios
Silence Therapeutics Plc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Silence Therapeutics Plc (SLN)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら